Cilengitide

Catalog No.S6387 Batch:S638703

Print

Technical Data

Formula

C27H40N8O7
Molecular Weight 588.66 CAS No. 188968-51-6
Solubility (25°C)* In vitro DMSO 100 mg/mL (169.87 mM)
Water Insoluble
Ethanol Insoluble
In vivo (Add solvents to the product individually and in order)
Clear solution
5% DMSO 95% Corn oil
1.25mg/ml Taking the 1 mL working solution as an example, add 50 μL of 25 mg/ml clear DMSO stock solution to 950 μL of corn oil and mix evenly. The mixed solution should be used immediately for optimal results. 
Clear solution
5%DMSO 40%PEG300 5%Tween80 50%ddH2O
5.0mg/ml Taking the 1 mL working solution as an example, add 50 μL of 100 mg/ml clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to clarify; then continue to add 500 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results. 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description Cilengitide (EMD 121974, EMD-12192, EMD-85189, NSC-​707544) is a potent and selective inhibitor of the integrins ανβ3 and ανβ5 with IC50 of 4 and 79 nM, respectively.
Targets
integrin ανβ3 [1]
(Cell-free assay)		 integrin ανβ5 [1]
(Cell-free assay)
4 nM 79 nM
In vitro

Cilengitide inhibits a receptor reported to activate KRAS named ITGAV. [2]

Protocol (from reference)

Cell Assay:

[2]
  • Cell lines

    MCF10A, HuMEC cells

  • Concentrations

    10 μM

  • Incubation Time

    1 h

  • Method

    MCF10A and HuMEC cells were plated at the center of wells in 6-well plates. 24 hours after plating, colonies were washed with PBS and cells were pretreated for 1 hour in media with or without 1 μM U0126, 1 μM LY294002,  1 μM infigratininb or 10 μM cilengitide. After pre-incubation, medium was replaced with medium with or without 4 ng/ml TGF-β1 as well as any inhibitor with which cells were pretreated. TGF-β1 was replenished every 48 hours. After 7 days, samples were harvested and processed for flow cytometry of EMT marker protein levels as described above.

    (Data sourced from selleck products)
Animal Study:

[1]
  • Animal Models

    Nude mice

  • Dosages

    10, 50, and 250 µg

  • Administration

    i.p.

Selleck's Cilengitide has been cited by 38 publications

hUC-MSCs-derived MFGE8 ameliorates locomotor dysfunction via inhibition of ITGB3/ NF-κB signaling in an NMO mouse model [ NPJ Regen Med, 2024, 9(1):4] PubMed: 38242900
Milk fat globule epidermal growth factor 8 alleviates liver injury in severe acute pancreatitis by restoring autophagy flux and inhibiting ferroptosis in hepatocytes [ World J Gastroenterol, 2024, 30(7):728-741] PubMed: 38515944
Tissue factor is a critical regulator of radiation therapy-induced glioblastoma remodeling [ Cancer Cell, 2023, 41(8):1480-1497.e9] PubMed: 37451272
Self-generated gradients steer collective migration on viscoelastic collagen networks [ Nat Mater, 2022, 10.1038/s41563-022-01259-5] PubMed: 35637338
Developmental endothelial locus-1 protects from hypertension-induced cardiovascular remodeling via immunomodulation [ J Clin Invest, 2022, e126155] PubMed: 35133978
Integrin β3-PKM2 pathway-mediated aerobic glycolysis contributes to mechanical ventilation-induced pulmonary fibrosis [ Theranostics, 2022, 12(14):6057-6068] PubMed: 36168620
Fibroblast growth factor receptor 4 promotes glioblastoma progression: a central role of integrin-mediated cell invasiveness [ Acta Neuropathol Commun, 2022, 10(1):65] PubMed: 35484633
Macrophage-like THP-1 Cells Derived from High-Density Cell Culture Are Resistant to TRAIL-Induced Cell Death via Down-Regulation of Death-Receptors DR4 and DR5 [ Biomolecules, 2022, 12(2)150] PubMed: 35204655
Cell clusters adopt a collective amoeboid mode of migration in confined nonadhesive environments [ Sci Adv, 2022, 8(39):eabp8416] PubMed: 36179021
Cellular mechanisms of cancer collective invasion and response to treatments [ HAL open science, 2022,  version 1 (17-06-2023)] PubMed: none

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.